Upadacitinib
Economic Operator with Whom the Contract Has Been Concluded
| Show detail | ||||||||
|---|---|---|---|---|---|---|---|---|
| 2427/2024-SML | 25. 11. 2024 | AbbVie s.r.o. | 22 068 314,24 | 19 703 852,00 | 22 068 314,24 | 19 703 852,00 | CZK |
Published Documents
| Show detail | |||||
|---|---|---|---|---|---|
| Písemná zpráva zadavatele_Upadacitinib_EP.pdf | Písemná zpráva zadavatele | 28. 11. 2024 11:29 | Dokument není zavirovaný |
List of Participants
| Show detail | ||||||
|---|---|---|---|---|---|---|
| AbbVie s.r.o. | Praha | 22 068 314,24 | 19 703 852,00 | CZK | Yes |